Should the contraceptive pill be available without prescription?

BMJ (Online)

Volumn 338, Issue 7688, 2009, Pages 202-203

  Grossman, Daniel ^a,b   Jarvis, Sarah ^c  

^a IBIS REPRODUCTIVE HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ROYAL COLLEGE OF GENERAL PRACTITIONERS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ORAL CONTRACEPTIVE AGENT;

CANCER RISK; CARDIOVASCULAR RISK; CHEMOPROPHYLAXIS; CLINICAL PRACTICE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HEALTH SURVEY; HORMONAL CONTRACEPTION; HUMAN; MARITAL THERAPY; MORTALITY; OVARY CANCER; PATIENT CARE; PREGNANCY RATE; PRESCRIPTION; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; SHORT SURVEY; UTERINE CERVIX CYTOLOGY; WORLD HEALTH ORGANIZATION;

EID: 61849140223     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.a3044     Document Type: Short Survey

References (0)